Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • concilladoC Offline
    concilladoC Offline
    concillado
    wrote on sidst redigeret af
    #226

    Man skulle da lige have taget lidt gevinsthjemtagning i 2250 😉

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gdn55
      wrote on sidst redigeret af
      #227

      Hvorfor det

      1 Reply Last reply
      0
      • concilladoC Offline
        concilladoC Offline
        concillado
        wrote on sidst redigeret af
        #228

        ...inden Trump-babyen gik i gang igen. "Kun" 3 år tilbage med hans rablende infantile vanvid xD

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #229

          ok gentogen , than we have something to look forward to

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #230

            DNB Carnegie løfter Genmabs anbefaling til "køb" og skruer pænt op for kursmålet https://proinvestor.com/investornyt/1405261/dnb-carnegie-lofter-genmabs-anbefaling-til-kob-og-skruer-paent-op-for-kursmalet

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #231

              hey gentogen , thinking again on that China part of the trial ; too many Asian patients in the trial was where Roche/Genentech got in trouble with Columvi wasn't it; they got a Complete Response Letter from the FDA for the reason that OS was much better in Asian patients compared to non-Asian patients so FDA determined OS was not proven for Americans

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #232

                and that was Columvi chemo combination and they
                still have the accelerated approval

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #233
                  • 4Q DARZALEX REVENUE $3.90B, EST. $3.75B
                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #234

                    https://ir.genmab.com/news-releases/news-release-details/genmab-announces-net-sales-darzalexr-daratumumab-2025

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #235

                      Far above top end of prognosis interval.

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Peter_Panik
                        wrote on sidst redigeret af
                        #236

                        Genmabs amerikanske partner Johnson & Johnson overgår analytikernes forventninger med sine salgstal for kræftmidlet Darzalex i fjerde kvartal.

                        Salget af Darzalex løber op i 3903 mio. dollar i perioden, mens analytikere havde ventet 3748 mio. dollar ifølge Bloomberg News.

                        I forhold til samme kvartal sidste år er Darzalex-salget steget 24 pct. i lokal valuta.

                        For hele 2025 endte Johnson & Johnsons salg af Darzalex, som Genmab får procenter af, på 14.351 mio. dollar.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Peter_Panik
                          wrote on sidst redigeret af
                          #237

                          Det viser onsdagens regnskab fra Johnson & Johnson.

                          Darzalex-salget lander dermed over Genmabs prognose for 2025 om et salg på 13,7 til 14,1 mia. dollar.

                          Genmab estimerede i sit seneste regnskab, at det vil modtage royalties fra salget af Darzalex på 2,3-2,4 mia. dollar i 2025.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Peter_Panik
                            wrote on sidst redigeret af
                            #238

                            Isoleret set et stærkt resultat

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #239

                              RYBREVANT / LAZCLUZE Q4 2025 US 146 Intl 70 WW 216 (Q3 2025 US 136 Intl 61 WW 198) (total 2025 734 vs 327 2024)

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #240

                                TALVEY Q4 2025 149 (Q3 122), totals 463 (287) /// TECVAYLI 176 (Q3 177) totals 670 (549)

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #241

                                  Very nice numbers indeed - and Ryb/Tec/Tal will probably start to accelerate much faster the comming years.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #242

                                    Hansen og Larsen diskuterer i denne uges afsnit af Investeringspodcasten Novo Nordisks comeback, Genmab og hvad Trumps trusler betyder for de danske investorer. https://proinvestor.com/boards/130810

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #243

                                      that would be great... in the mean time Dara just keeps performing, just amazing... ignoring the clusterfuck arbitrage, it is just an amazing success. i still remember us all laughing with McJean predicting 15bn in sales... i thought it was impossible at the time...

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #244

                                        Jeg har nu altid syntes, at Mcjean var klarsynet. Håber på, at han "genopstår" herinde.

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #245

                                          Onsdagens aktier: Novo i bunden og Genmab i toppen af rødt C25 https://proinvestor.com/investornyt/1405493/onsdagens-aktier-novo-i-bunden-og-genmab-i-toppen-af-rodt-c25

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper